Taysha Gene Therapies, Inc.: Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome

The 2022 Option Agreement between Astellas and Taysha has expired Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value with full strategic fle ...

[Latest] Global Biofeedback Instrument Market Size/Share Worth USD 340 Million by 2034 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, T…

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
IEEE

YOLO-based Food Damage Detection: An Automated Approach for Quality Control in Food Industry

Abstract: In modern food production and quality control, accuracy and efficiency are paramount. This study presents a pioneering application of artificial intelligence technology that integrates the ...
Science-Based MedicineOpinion

RFK Jr. is definitely coming for your vaccines, part 4: Aluminum edition (or: Everything old is new again…again)

Last week, news stories reported that HHS Secretary Robert F. Kennedy Jr. had convened an "aluminum working group." Among the ...

IsoEnergy to Acquire Toro Energy, Strengthening a Top-Tier Uranium Portfolio in a Rising Market

PERTH, Australia - Oct. 13, 2025 - IsoEnergy Ltd. ("IsoEnergy") (NYSE American: ISOU) (TSX: ISO) and Toro Energy Ltd. ("Toro") (ASX: TOE) are pleased to announce that they have entered into a scheme ...